Assessment of Dialysis Initiation by a Fuzzy Mathematics Equation
NCT03385902 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 388
Last updated 2026-05-08
Summary
The purpose of this study is to evaluate the impact of the optimal and late initiation of dialysis on the mortality and quality of life in end-stage renal disease (ESRD) patients by the Dialysis Initiation based on Fuzzy mathematics Equation (DIFE), which is a novel equation for the assessment of timing of dialysis initiation established by Fuzzy mathematics.
Conditions
Interventions
- OTHER
-
optimal start time
patients will start hemodialysis when their DIFE reach 35, and can not wait if the DIFE decline to 30.
- OTHER
-
late start time
patients will start hemodialysis when their DIFE less than 30
Sponsors & Collaborators
-
Chinese PLA General Hospital
collaborator OTHER -
Fudan University
collaborator OTHER -
RenJi Hospital
collaborator OTHER -
Beijing Friendship Hospital
collaborator OTHER -
Huashan Hospital
collaborator OTHER -
West China Hospital
collaborator OTHER -
First Affiliated Hospital, Sun Yat-Sen University
collaborator OTHER -
Chinese Academy of Medical Sciences, Fuwai Hospital
collaborator OTHER -
First Affiliated Hospital of Harbin Medical University
collaborator OTHER -
The Second Affiliated Hospital of Harbin Medical University
collaborator OTHER -
General hospital of benxi iron and steel co.
collaborator UNKNOWN -
Dalian Municipal Central Hospital
collaborator OTHER -
An Steel Group Hospital
collaborator UNKNOWN -
The First Affiliated Hospital of the Fourth Military Medical University
collaborator OTHER -
General Hospital of Mining Industry Group Fuxin
collaborator UNKNOWN -
Affiliated Zhongshan Hospital of Dalian University
collaborator OTHER -
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
collaborator OTHER -
General Hospital of Ningxia Medical University
collaborator OTHER -
Lanzhou University Second Hospital
collaborator OTHER -
First Affiliated Hospital of Xinjiang Medical University
collaborator OTHER -
First Hospital of China Medical University
collaborator OTHER -
Central Hospital Affiliated to Shenyang Medical Collage
collaborator OTHER -
First Affiliated Hospital Xi'an Jiaotong University
collaborator OTHER -
Henan Provincial People's Hospital
collaborator OTHER -
Guangdong Provincial People's Hospital
collaborator OTHER -
The First Affiliated Hospital of Dalian Medical University
lead OTHER
Principal Investigators
-
Hongli Lin, MD, PhD · The First Affiliated Hospital of Dalian Medical University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-14
- Primary Completion
- 2024-05-20
- Completion
- 2024-05-20
Countries
- China
Study Locations
More Related Trials
-
Coronary Revascularization in Patients On Dialysis in China-Retrospective Registry
NCT05841082 ·Status: UNKNOWN
-
A Clinical Study on the Impact of Hemoperfusion on the Prognosis of Uremic Patients Undergoing Maintenance Hemodialysis
NCT06981559 ·Status: NOT_YET_RECRUITING
-
Emotion and Cognitive Function and Brain Imaging Change in HD Patients
NCT05137470 ·Status: RECRUITING
-
Coronary Revascularization in Patients With Dialysis in China
NCT04953819 ·Status: UNKNOWN
-
AI-Driven Prediction of Dialysis Outcome With EHR
NCT06791447 ·Status: RECRUITING
-
Comparison of the Impact of Dialysis Treatment Type on Patient Survival
NCT00510549 ·Status: COMPLETED ·Phase: PHASE4
-
Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula
NCT06199609 ·Status: COMPLETED
-
Changes in Renal Perfusion During Hemodialysis in Patients with End-stage Renal Disease
NCT06587997 ·Status: NOT_YET_RECRUITING
-
Preference of Life-Sustaining Treatment Among Patients With End Stage Renal Disease
NCT05878171 ·Status: RECRUITING
-
Effect of Different Dialysis Dosage on Prognosis in Maintenance Peritoneal Dialysis Patients
NCT00912821 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of On-Line Hemodiafiltration(HDF) on Vascular Health in Chronic Hemodialysis Patients
NCT00532597 ·Status: UNKNOWN ·Phase: PHASE4
-
Impact of the Implementation of CKD Coordination Function on Dialysis Initiation Frequency in Emergency
NCT02878902 ·Status: COMPLETED
-
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
NCT00739843 ·Status: TERMINATED
-
Impact of Residual Renal Function on Complications in Chronic Hemodialysis Patients
NCT03854513 ·Status: UNKNOWN
-
Seasonal Differences in Home Dialysis Uptake and Initiating Dialysis in the Hospital
NCT04935827 ·Status: COMPLETED
-
Urgent-start Peritoneal Dialysis in ESRD Patients:A Multi-center Study
NCT02946528 ·Status: COMPLETED ·Phase: NA
-
Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China
NCT01413074 ·Status: TERMINATED ·Phase: NA
-
Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients
NCT06002529 ·Status: UNKNOWN ·Phase: NA
-
Hemodialysis-Induced Renal Perfusion Decline: Unraveling the Pathophysiological Mechanisms Linking Intradialytic Circulatory Stress to Residual Renal Function Loss
NCT07003828 ·Status: ACTIVE_NOT_RECRUITING
-
Risk Factors and Application of Risk Management Strategies in Hemodialysis Patients Complicated With Heart Failure
NCT06959927 ·Status: COMPLETED ·Phase: NA
-
The Effect and Safety of Hemodialysis and Hemoperfusion on Severe Renal Osteopathy and Itching in Uremia Patients
NCT02747979 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Quality of Life on Peritoneal Dialysis Versus Hemodialysis in China
NCT02378350 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Dialysis Therapies on Cognitive Function
NCT00597103 ·Status: COMPLETED
-
The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients
NCT04600219 ·Status: UNKNOWN
-
Impact on Quality of Life of Symptoms Routine E-monitoring Among Dialysis Patients.
NCT06257134 ·Status: RECRUITING ·Phase: NA